Possible participation of acidic pH in bone resorption in middle ear cholesteatoma

Laryngoscope

Volumn 124, Issue 1, 2014, Pages 245-250

  Nguyen, Khac Hung ^a,b   Suzuki, Hideaki ^a   Ohbuchi, Toyoaki ^a   Wakasugi, Tetsuro ^a   Koizumi, Hiroki ^a   Hashida, Koichi ^a   Baba, Ryoko ^a   Morimoto, Hiroyuki ^a   Doi, Yoshiaki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Thai Nguyen University of Medicine and Pharmacy   (Viet Nam)

Author keywords

bone resorption; Cholesteatoma; filaggrin; permeability; pH

Indexed keywords

FILAGGRIN; KERATIN; LANTHANUM CHLORIDE;

ACIDITY; ARTICLE; BASEMENT MEMBRANE; CHOLESTEATOMA; CONFOCAL LASER SCANNING MICROSCOPE; EPITHELIUM; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SPACE; MAJOR CLINICAL STUDY; MIDDLE EAR; MIDDLE EAR MUCOSA; OSTEOLYSIS; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; COMPLICATION; ETIOLOGY; METABOLISM; PH;

BONE RESORPTION; CHOLESTEATOMA, MIDDLE EAR; EPITHELIUM; HUMANS; HYDROGEN-ION CONCENTRATION;

BONE RESORPTION; CHOLESTEATOMA; FILAGGRIN; PERMEABILITY; PH;

EID: 84895842332     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23883     Document Type: Article

References (42)

1. Abramson M, Huang CC,. Localization of collagenase in human middle ear cholesteatoma. Laryngoscope 1977; 87: 771-791.
2. Moriyama H, Honda Y, Huang CC, Abramson M,. Bone resorption in cholesteatoma: epithelial-mesenchymal cell interaction and collagenase production. Laryngoscope 1987; 97: 854-859.
3. Jung TT, Juhn SK,. Prostaglandins in human cholesteatoma and granulation tissue. Am J Otol 1988; 9: 197-200.
4. Cheshire IM, Blight A, Ratcliffe WA, Proofs DW, Heath DA,. Production of parathyroid-hormone-related protein by cholesteatoma cells in culture. Lancet 1991; 338: 1041-1043.
5. Kurihara A, Toshima M, Yuasa R, Takasaka T,. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1α. Ann Otol Rhinol Laryngol 1991; 100: 989-998.
6. Kakiuchi H, Kinoshita K, Katoh Y, Tabata T,. Interleukin-1 of cholesteatomatous keratinocytes. Ann Otol Rhinol Laryngol Suppl 1992; 157: 32-38.
7. Fujioka O, Huang CC,. Platelet-derived growth factor in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1994; 251: 199-204.
8. Cheshire IM, Blight A, Ratcliffe WA, Proops DW,. In vitro production of parathyroid hormone-related protein by cholesteatoma and normal skin. Clin Otolaryngol Allied Sci 1995; 20: 448-452.
9. Bujia J, Kim C, Ostos P, Kastenbauer E, Hultner L,. Role of interleukin-6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol 1996; 253: 152-157.
10. Bujia J, Kim C, Ostos P, Sudhoff H, Kastenbauer E, Hultner L,. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol 1996; 253: 252-255.
11. Bujia J, Kim C, Boyle D, Hammer C, Firestein G, Kastenbauer E,. Quantitative analysis of interleukin-1α gene expression in middle ear cholesteatoma. Laryngoscope 1996; 106: 217-220.
12. Schonermark M, Mester B, Kempf HG, Blaser J, Tschesche H, Lenarz T,. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol 1996; 116: 451-456.
13. Kim TT, Chen CT, Huang CC,. Expression of annexin II in human middle ear cholesteatoma. Otolaryngol Head Neck Surg 1998; 118: 324-328.
14. Akimoto R, Pawankar R, Yagi T, Baba S,. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-a, intercellular adhesion molecule-1, interleukin-1α and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000; 62: 257-265.
15. Hansen T, Unger RE, Gaumann A, et al. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma. Mod Pathol 2001; 14: 1226-1231.
16. Yetiser S, Satar B, Aydin N,. Expression of epidermal growth factor, tumor necrosis fastor-α, and interleukin-1α in chronic otitis media with or without cholesteatoma. Otol Neurotol 2002; 23: 647-652.
17. Hamzei M, Ventriglia G, Hagnia M, et al. Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope 2003; 113: 436-442.
18. Jeong JH, Park CW, Tae K, et al. Expression of RANKL and OPG in middle ear cholesteatoma tissue. Laryngoscope 2006; 116: 1180-1184.
19. Olszewska E, Olszewski S, Borzym-Kluczyk M, Zwierz K,. Role of N-acetyl-β-d-hexosaminidase in cholesteatoma tissue. Acta Biochim Pol 2007; 54: 365-370.
20. Olszewska E, Borzym-Kluczyk M, Olszewski S, Zwierz K,. Catabolism of glycoconjugates in chronic otitis media with cholesteatoma. J Investig Med 2007; 55: 248-254.
21. v mice. Hear Res 2005; 209: 53-59.
22. Ruedi L,. Cholesteatosis of the attic. J Laryngol Otol 1958; 72: 593-609.
23. Chole RA, McGinn, MD, Tinling SP,. Pressure-induced bone resorption in the middle ear. Ann Otol Rhinol Laryngol 1985; 94: 165-170.
24. Wolfman DE, Chole RA,. Osteoclast stimulation by positive middle-ear air pressure. Arch Otolaryngol Head Neck Surg 1986; 112: 1037-1042.
25. Orisek BS, Chole RA,. Pressure exerted by experimental cholesteatomas. Arch Otolaryngol Head Neck Surg 1987; 113: 386-391.
26. Huang CC, Yi ZX, Yuan QG, Abramson M,. A morphometric study of the effects of pressure on bone resorption in the middle ear of rats. Am J Otol 1990; 11: 39-43.
27. Walsh TE, Covell WP, Ogura JH,. The effect of cholesteatosis on bone. Ann Otol Rhinol Laryngol 1951; 60: 1100-1113.
28. Kaneko Y, Yuasa R, Ise I, et al. Bone destruction due to the rupture of a cholesteatoma sac: a pathogenesis of bone destruction in aural cholesteatoma. Laryngoscope 1980; 90: 1865-1870.
29. Iino Y, Hoshino E, Tomioka S, Takasaka T, Kaneko Y, Yuasa R,. Organic acids and anaerobic microorganisms in the contents of the cholesteatoma sac. Ann Otol Rhinol Laryngol 1983; 92: 91-96.
30. Suzuki C, Ohtani I,. Bone destruction resulting from rupture of a cholesteatoma sac: temporal bone pathology. Otol Neurotol 2004; 25: 674-677.
31. Chen ZF, Darvell BW, Leung VWH,. Hydroxyapatite solubility in simple inorganic solutions. Arch Oral Biol 2004; 49: 359-367.
32. Chan A, Mauro T,. Acidification in the epidermis and the role of secretory phospholipases. Dermatoendocrinol 2011; 3: 84-90.
33. Barbour ME, Parker DM, Allen GC, Jandt KD,. Human enamel dissolution in citric acid as a function of pH in the range 2.30
34. Magalhaes AC, Wiegand A, Rios D, Buzalaf MA, Lussi A,. Fluoride in dental erosion. Monogr Oral Sci 2011; 22: 158-170.
35. Linck G, Petrovic A, Shambaugh GE Jr,. Fluoride and calcium content of bone in otosclerotic patients. Arch Otolaryngol 1967; 86: 412-418.
36. Torrisi L, Foti G, Campisano SU,. Fluorine microanalysis in teeth. Clin Mater 1990; 5: 139-145.
37. Wright CG, Meyerhoff WL,. Pathology of otitis media. Ann Otol Rhinol Laryngol Suppl 1994; 163: 24-26.
38. Gerami H, Naghavi E, Wahabi-Moghadam M, Forghanparast K, Akbar MH,. Comparison of preoperative computerized tomography scan imaging of temporal bone with the intra-operative findings in patients undergoing mastoidectomy. Saudi Med J 2009; 30: 104-108.
39. Barbour ME, Lussi A, Shellis RP,. Screening and prediction of erosive potential. Caries Res 2011; 45 (suppl 1): 24-32.
40. O'Regan GM, Sandilands A, McLean WH, Irvine AD,. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2009; 124 (suppl 2): R2-R4.
41. Novak N, Baurecht H, Schafer T, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008; 128: 1430-1435.
42. Kim BE, Leung DY,. Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol Res 2012; 4: 12-16.